Drug Shortage Report for REMIFENTANIL FOR INJECTION

Last updated on 2020-01-24 History
Report ID 104313
Drug Identification Number 02344424
Brand name REMIFENTANIL FOR INJECTION
Common or Proper name REMIFENTANIL HCL INJECTION 1MG
Company Name TEVA CANADA LIMITED
Market Status CANCELLED POST MARKET
Active Ingredient(s) REMIFENTANIL
Strength(s) 1MG
Dosage form(s) POWDER FOR SOLUTION
Route of administration INTRAVENOUS
Packaging size 10pk
ATC code N01AH
ATC description ANESTHETICS, GENERAL
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2020-01-22
Estimated end date Unknown
Actual end date
Shortage status Actual shortage
Updated date 2020-01-24
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 30 NOVOPHARM COURT
TORONTO, ONTARIO
CANADA M1B 2K9
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v2 2020-01-24 French Compare
v1 2020-01-24 English Compare

Showing 1 to 2 of 2